Founded in 1986, Tullis Health Investors is a Palm Beach, Florida venture capital firm. They invest in the medical devices, healthcare services, healthcare infrastructure and distribution, healthcare information technology, biotechnology and pharmaceuticals sectors. Tullis Health Investors manage five funds focused on investments in North America and Asia.
Tullis Health Investors has made investments in Exagen, Estech, CareSync, OrthoSensor, Surefire Medical, BioBehavioral Diagnostics, Synageva Biopharma, Aldagen, Atritech, Impulse Monitoring and TransMolecular.
Tullis Health Investors exited their investments in Exagen, CareSync, Synageva BioPharma, Coherex Medical, Estech, Aldagen, Atritech, Myocor, Adiana, BioRexis and TransMolecular.
Timeline
Funded Companies
AtriCure, Inc. is a medical device company that provides innovative solutions for the treatment of atrial fibrillation (Afib) and related conditions.
A biopharmaceutical company that develops and commercializes protein therapeutics for the treatment of rare diseases
BioBehavioral Diagnostics was founded in 2004 and manufactures technologies for the diagnosis and management of neurological and psychiatric conditions.
A company developing regenerative medicines for wound care, inflammation and angiogenesis
People
Barbara Bierer, MD
Domain Partner
Darlene Franze
Vice President, Administration
Das Narayandas
Advisory Board
David Leffel, MD
Domain Partner
Jim Tullis
Founding General Partner
John Tullis
Managing General Partner
Melanie Oldeman
Investor Relations Administrator
Neil Ryan
Domain Partner
Nora Mende
Chief Financial Officer
Stephanie Moss
Fund Controller
Tina Nova, PhD
Domain Partner
Waneta Tuttle
Advisory Board Member
